Article
Resistant-Associated Substitutions Do Not Affect HCV RNA and HCV Core Antigen Clearance…
Infection and Drug Resistance · 2022 · Chen H, Liu J, Kang Q, Luo H, Tan N, Pan J, Yang Y, Yu M, Liu D, Xi H, Han Y, Cheng R, Yu Y, Xu X
Key facts
| Title | Resistant-Associated Substitutions Do Not Affect HCV RNA and HCV Core Antigen Clearance During Direct-Acting Antiviral Agent Treatment in a Real-World Setting |
|---|---|
| First author | Chen H, Liu J, Kang Q, Luo H, Tan N, Pan J, Yang Y, Yu M, Liu D, Xi H, Han Y, Cheng R, Yu Y, Xu X |
| Journal | Infection and Drug Resistance |
| Published | Jun 28, 2022 |
| DOI | 10.2147/IDR.S352873 |
| Product codes mentioned | JJH |
At a glance
- None FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1